It isn't ideal I know, but it's unfortunately designed to get people to sell down. Just be patient. Remind yourself of fundamentals and what's happening now:
- Revenue is up 18% year on year for FY24
- Extremely strong cash position ($19M in reserves)
- Contract renewals and expansions in NSW, QLD and the US (0.8M in Georgia)
- Revenue from outside AUS went from 1% to 4%, so in other words, there's huge room for growth
- Named 2024 Vic scaleup of year (more exposure than anything else)
- Won CIHT Road Safety award in UK, which is a big deal https://roadsafetygb.org.uk/news/acusensus-road-safety-award-proves-distracted-driving-being-taken-seriously/
- 2 lots of insider buying within the last 6 months
- There's a patent case with a close competitor, if they breached our patent well they're majorly screwed for future tenders
- RAC offered huge support for ACE in the UK (the UK version of the RACV who have a lot of authority and pull there)
- We just hired Violet snell, one the pioneers of AI machine learning, it's a huge scalp
- State governments have all been increasing their spend on road safety, so the money is growing
And just now someone purchased over $150k of shares this arvo. So that's pretty much vindication with regards to what i was saying about the SP being driven down to allow someone to enter at a lower price. They've obviously been pushing it progressively lower from 600 to 550 to hit this mark, purely so that this big kahuna can purchase such a large amount on market. This is the proof right here of manipulation. I don't expect it to be drive down much more now that this instigator has occurred (assuming i'm right).
Trust me when I say, just hold onto your shares.
- Forums
- ASX - By Stock
- Ann: Acusensus FY24 Results Webinar
ACE
acusensus limited.
Add to My Watchlist
1.58%
!
96.5¢

It isn't ideal I know, but it's unfortunately designed to get...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
96.5¢ |
Change
0.015(1.58%) |
Mkt cap ! $135.3M |
Open | High | Low | Value | Volume |
95.5¢ | 98.5¢ | 95.5¢ | $10.11K | 10.51K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 70843 | 95.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
99.0¢ | 310 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 70843 | 0.950 |
1 | 5213 | 0.900 |
1 | 590 | 0.850 |
2 | 1500 | 0.825 |
2 | 41831 | 0.820 |
Price($) | Vol. | No. |
---|---|---|
0.990 | 310 | 1 |
1.020 | 500 | 1 |
1.040 | 7403 | 1 |
1.100 | 18950 | 2 |
1.175 | 2500 | 1 |
Last trade - 15.44pm 01/07/2025 (20 minute delay) ? |
Featured News
ACE (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Dr. Steven Gourlay, CEO
Dr. Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online